Abstract

Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions

Author(s): Parish Roy C

Issue: Nov/Dec 2009 - Geriatric Compounding

Page(s): 572-573

Download in electronic PDF format for $75
  • Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Page 1
  • Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Page 2

Abstract

A high-performance liquid chromatographic assay method was developed to facilitate stability studies of extemporaneously compounded oral liquid formulations of ziprasidone. The method is simple and precise within the needs of the pharmaceutical profession. The throughput time is approximately 7 minutes per sample. The method is easily adaptable for individual needs.

Related Keywords

  • ziprasidone mesylate
  • psychotropic agent
  • sedation
  • sedative
  • agitation
  • stability
  • assay

Related Categories

  • PEER-REVIEWED
  • QUALITY CONTROL
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2009
Pg. 572-573
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions
Author(s): Parish Roy C
Nov/Dec 2021
Pg. 509
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2009
Pg. 254-258
Stability of Pergolide Mesylate Oral Liquid at Room Temperature
Author(s): Shank Brandon R, Ofner Clyde M III
Jul/Aug 2002
Pg. 255-256
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Author(s): Mason Dave
Sep/Oct 1997
Pg. 339
Assaying Progesterone in Extemporaneously Prepared Suppositories
Author(s): Al-Achi Antoine, Webster Kathy, Greenwood Robert, Nicol Scott
Sep/Oct 2018
Pg. 410
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 251
Trovafloxacin Mesylate 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 498
Benztropine Mesylate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2015
Pg. 69
Phentolamine Mesylate 5-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 318
Dolasetron Mesylate 20-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 164-170
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Author(s): Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2015
Pg. 144
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 503
Dihydroergotamine Mesylate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 240-246
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Author(s): Khokhlova Kateryna O, Zdoryk Oleksandr A
Jul/Aug 2010
Pg. 340
Fenoldopam Mesylate Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 62-64
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets
Author(s): Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap
Jan/Feb 2001
Pg. 9-12
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Author(s): Schotik Debora